NL
EXC icon

NorthAvenue LLC’s Exelon EXC Stock Holding History

NorthAvenue LLC’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$262 – 305
2025
Q4 		$262 Buy
+6
New +$274 ﹤0.01% 317

Other funds holding EXC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

NorthAvenue LLC's EXC Position: Q1 2026 in Review

NorthAvenue LLC sold out of Exelon (EXC) in Q1 2026, closing a stake of 6 shares — an estimated $262 sold.

NorthAvenue LLC first reported a position in EXC in Q4 2025 and held it in 1 quarter. The position peaked at $262 in Q4 2025. 1,278 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • NorthAvenue LLC reported no remaining Exelon position as of Q1 2026 after selling out during the quarter.
  • NorthAvenue LLC sold 6 Exelon shares in Q1 2026, an estimated $262.
  • NorthAvenue LLC first reported a position in Exelon in Q4 2025 and held it in 1 quarter.
  • NorthAvenue LLC's Exelon position peaked at $262 in Q4 2025.
  • 1,278 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.